Incidence of Invasive Fungal Disease in Patients Receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis
Latest Information Update: 17 Feb 2022
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Mycoses
- Focus Therapeutic Use
- Acronyms KIASII
- 01 Apr 2020 Status changed from active, no longer recruiting to completed.
- 24 Jan 2019 Planned End Date changed from 30 May 2020 to 31 Oct 2019.
- 24 Jan 2019 Status changed from recruiting to active, no longer recruiting.